Optimizing Human Performance in Mobile Text Entry

Although text entry on mobile phones is abundant, research strives to achieve desktop typing performance "on the go". But how can researchers evaluate new and existing mobile text entry techniques? How can they ensure that evaluations are conducted in a consistent manner that facilitates comparison? What forms of input are possible on a mobile device? Do the audio and haptic feedback options with most touchscreen keyboards affect performance? What influences users' preference for one feedback or another? Can rearranging the characters and keys of a keyboard improve performance? This dissertation answers these questions and more. The developed TEMA software allows researchers to evaluate mobile text entry methods in an easy, detailed, and consistent manner. Many in academia and industry have adopted it. TEMA was used to evaluate a typical QWERTY keyboard with multiple options for audio and haptic feedback. Though feedback did not have a significant effect on performance, a survey revealed that users' choice of feedback is influenced by social and technical factors. Another study using TEMA showed that novice users entered text faster using a tapping technique than with a gesture or handwriting technique. This motivated rearranging the keys and characters to create a new keyboard, MIME, that would provide better performance for expert users. Data on character frequency and key selection times were gathered and used to design MIME. A longitudinal user study using TEMA revealed an entry speed of 17 wpm and a total error rate of 1.7% for MIME, compared to 23 wpm and 5.2% for QWERTY. Although MIME's entry speed did not surpass QWERTY's during the study, it is projected to do so after twelve hours of practice. MIME's error rate was consistently low and significantly lower than QWERTY's. In addition, participants found MIME more comfortable to use, with some reporting hand soreness after using QWERTY for extended periods

RotoSwype : word-gesture typing using a ring

Funding: NSERC Discovery Grant #2018-05187, the Canada Foundation for Innovation Infrastructure Fund “Facility for Fully Interactive Physio-digital Spaces” (#33151), and Ontario Early Researcher Award #ER16-12-184.We propose RotoSwype, a technique for word-gesture typing using the orientation of a ring worn on the index finger. RotoSwype enables one-handed text-input without encumbering the hand with a device, a desirable quality in many scenarios, including virtual or augmented reality. The method is evaluated using two arm positions: with the hand raised up with the palm parallel to the ground; and with the hand resting at the side with the palm facing the body. A five-day study finds both hand positions achieved speeds of at least 14 words-per-minute (WPM) with uncorrected error rates near 1%, outperforming previous comparable techniques.Postprin

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.

BACKGROUND: Thrombosis and inflammation may contribute to morbidity and mortality among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation would improve outcomes in critically ill patients with Covid-19. METHODS: In an open-label, adaptive, multiplatform, randomized clinical trial, critically ill patients with severe Covid-19 were randomly assigned to a pragmatically defined regimen of either therapeutic-dose anticoagulation with heparin or pharmacologic thromboprophylaxis in accordance with local usual care. The primary outcome was organ support-free days, evaluated on an ordinal scale that combined in-hospital death (assigned a value of -1) and the number of days free of cardiovascular or respiratory organ support up to day 21 among patients who survived to hospital discharge. RESULTS: The trial was stopped when the prespecified criterion for futility was met for therapeutic-dose anticoagulation. Data on the primary outcome were available for 1098 patients (534 assigned to therapeutic-dose anticoagulation and 564 assigned to usual-care thromboprophylaxis). The median value for organ support-free days was 1 (interquartile range, -1 to 16) among the patients assigned to therapeutic-dose anticoagulation and was 4 (interquartile range, -1 to 16) among the patients assigned to usual-care thromboprophylaxis (adjusted proportional odds ratio, 0.83; 95% credible interval, 0.67 to 1.03; posterior probability of futility [defined as an odds ratio <1.2], 99.9%). The percentage of patients who survived to hospital discharge was similar in the two groups (62.7% and 64.5%, respectively; adjusted odds ratio, 0.84; 95% credible interval, 0.64 to 1.11). Major bleeding occurred in 3.8% of the patients assigned to therapeutic-dose anticoagulation and in 2.3% of those assigned to usual-care pharmacologic thromboprophylaxis. CONCLUSIONS: In critically ill patients with Covid-19, an initial strategy of therapeutic-dose anticoagulation with heparin did not result in a greater probability of survival to hospital discharge or a greater number of days free of cardiovascular or respiratory organ support than did usual-care pharmacologic thromboprophylaxis. (REMAP-CAP, ACTIV-4a, and ATTACC ClinicalTrials.gov numbers, NCT02735707, NCT04505774, NCT04359277, and NCT04372589.)